1. <span id="izpls"></span>

    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Company News
    Bay Area New Drug Exchange 2022 Spring Dinner Salon was successfully held in Guangzhou
    作者:博濟醫藥 時間:2022-02-27 來源:博濟醫藥
    Recently, the Bay Area New Drug Exchange 2022 Spring Dinner Salon, hosted by Guangdong Biomedical Innovation Technology Association Bay Area New Drug Exchange and organized by Boji Pharmaceutical, was held at Guangzhou Nikko Hotel. The salon attracted nearly 60 biopharmaceutical industry leaders from Guangdong, Hong Kong and Macau Bay Area to participate in it.

    The theme of this salon is "New drug R&D strategy under the new situation and discussion on the similarities and differences of new drug review in China and the United States", which aims to promote the process of biopharmaceutical R&D innovation in the Greater Bay Area under the new situation, grasp the favorable policies of biopharmaceutical industry in the "Guangdong, Hong Kong and Macao Greater Bay Area", and discuss the industry The aim is to promote the process of biopharmaceutical R&D innovation in the Greater Bay Area under the new situation, grasp the favorable policies of the biopharmaceutical industry in the Greater Bay Area, and discuss the innovative development path of the industry. In particular, the recent setback of domestic PD-1's first FDA clearance, the new drug R&D and US-China review and regulation topics discussed in this conference are quite realistic considerations.
     
    • Phone:400-0020-628
    • Address:Clinical Center:7th Floor, Building A, Vanke Cloud Plaza, 1933 Huaguan Road, Tianhe District, Guangzhou / Laboratory Address:No.62,Nanxiang One Road,Huangpu Disrict,Guangzhou
    Copyright ? Boji Medical Technology Co., Ltd. All Rights Reserved 粵ICP備13039920號 (粵)—非經營性—2020-0084 Powered by vancheer
    Copyright ? Boji Medical Technology Co., Ltd. All Rights Reserved 粵ICP備13039920號 (粵)—非經營性—2020-0084 Powered by vancheer
    JAPAN18XXXXHD VIDEOS日本